Table 1 Patient demographics for all 38 patients put on study
From: Phase II study of erlotinib (OSI-774) in patients with metastatic colorectal cancer
Patient demographic | No. of patients (range) |
|---|---|
Age (median years) | 63.9 (40.9, 78.1) |
Gender | |
Female : male | 13 : 25 |
ECOG PS | |
0 : 1 | 21 : 17 |
No. of prior regimens | |
1 : 2 : 3 | 25 : 10 : 3 |
Prior therapy | |
Adjuvant chemotherapy | 16 |
Metastatic chemotherapy | 32 |
Radiotherapy | 12 |
Target/nontarget sites | |
Median (range) | 5 (1, 10)/2 (0, 5) |
Nodes | 19/15 |
Liver | 28/15 |
Lung | 10/16 |
Other | 7/6 |
